- FDA vaccine chief to step down in April
- FDA, states collaborate to lower drug prices
- 84% of primary care providers say they have key role in mental healthcare: Survey
- 84% of primary care providers say they have key role in mental healthcare: Survey
- SAMHSA offers $69.1M in behavioral health grants
- California to invest $65M in new mental health, housing community
- Florida hospital selects new EHR
- New Mexico governor signs sweeping healthcare reforms: 5 things to know
- Kettering Health faces 44 lawsuits over cyberattack
- 10 hospitals, health systems looking for CFOs
- 10 hospitals, health systems looking for CFOs
- Highmark Health generates $28M in value with Google AI
- Hiring red flags for dental employers to watch out for
- 4 health systems with boosted outlooks
- 4 health systems with boosted outlooks
- Alabama dentist sentenced to 15 years in prison for arson, insurance fraud
- We turned off the phones and our practice got busier
- Allina physicians, NPs, PAs back open-ended strike
- ‘This is how we know if we’re winning or losing’: Inside Grand Mental Health’s KPI strategy
- The cardiology physician shortage by state by 2036
- How dentists can keep up with rising patient expectations
- New leadership appointments across 5 specialties
- Among pregnant ED patients, Tylenol use fell 10% after Trump linked drug to autism risk
- Henry Schein opens integrated dental-medical training facility
- Henry Schein opens medical-dental integrated ASC
- Why Behavioral Health Needs an Operating System, Not Another Point Solution
- What’s the status of the federal noncompete ban? 5 notes
- North Carolina appeals court rejects AdventHealth CON complaint
- Telehealth growth hasn’t increased rural behavioral healthcare access: Study
- The NIH Workforce Is Its Smallest in Decades. Here’s the Work Left Behind.
- 16 hospitals closing departments or ending services
- Texas dental school to launch oral surgery residency program
- Trump administration weighs looser policies on nursing home antipsychotic use
- 62 ophthalmology departments ranked by NIH funding
- California oral surgery practice suffers data breach
- Private equity’s big-money deals are back: 5 trends for ASCs and physicians
- Virginia board denies dentist’s license reinstatement request
- Bill to reauthorize funding for CDC’s oral health program introduced: 5 things to know
- Trial compares genetic risk-sharing methods for colorectal cancer
- UPMC acquires Pennsylvania GI practice
- North Carolina launches mobile crisis dispatch pilot
- HCA New Hampshire hospital to end outpatient mental health services
- HCA New Hampshire hospital to end outpatient mental health services
- Ohio dental board revokes dentist’s anesthesia permit, suspends license
- Virginia dental practice reopens after fire
- BCBS Michigan updates, clarifies policy set to cut 50% from some E/M payments with ‘modifier 25’
- KFF: A look at Part D enrollment trends for 2026
- Lonza hands off capsule business to investment firm Lone Star in $3B deal
- Fitch downgrades Michigan hospital’s credit rating
- Some Patients Keep Weight off With Fewer GLP-1 Injections, Study Finds
- Christus Health doubles operating income in H1
- Democrats press 11 pharmas for 'any evidence' their Trump pricing deals deliver savings for Medicaid
- Democrats press 11 pharmas for 'any evidence' their Trump pricing deals deliver savings for Medicaid
- RFK Jr. Urges Medical Schools To Add More Nutrition Training
- Sixth Measles Case Confirmed in New Mexico Jail
- Sanofi strikes deal with Brazil's EMS to sell generics manufacturer Medley
- Philips unveils Rembra CT for acute and high-demand imaging environments
- Philips unveils Rembra CT for acute and high-demand imaging environments
- 45,000 Halo Magic Sleepsuits For Babies Recalled Over Choking Risk
- Super Bowl, Winter Olympics defined TV drug ad spending in February, led by AbbVie’s Rinvoq
- Op-Ed—American healthcare has a pricing problem
- Taiwan earmarks $755M for multi-year drug supply resilience program
- GLP-1 Weight-Loss Drugs Prove Effective Across Diverse Patient Groups
- Angry Teens May Age Faster, Study Finds
- Chronic Pain Can Make Noise Unbearable By Rewiring The Brain, Study Says
- Telemedicine Not Closing the Mental Health Gap in Rural Areas
- Racial Disparities Persist In Lung Cancer Treatment, Study Finds
- Peanut Allergy Risk Higher If Older Sibs Eat Peanuts, Study Finds
- FDA to end 9-month advisory committee drought with April review of AstraZeneca’s oral SERD, Truqap
- Pfizer breaks into obesity market in China with approval for Sciwind-partnered GLP-1
- This Doctor-Senator Who Backed RFK Jr. Now Faces a Fight for His Job — And His Legacy
- The People — And Research — Lost in the NIH Exodus
- Six Federal Scientists Run Out by Trump Talk About the Work Left Undone
- Servier to widen rare cancer offerings with $2.5B buyout of Day One and glioma drug Ojemda
- Fierce Pharma Asia—Kyowa ends OX40 program; Sanofi licenses first-in-class drug; BioNTech advances Duality ADC
- 47,000 comments on MA payment rule for 2027 breaks CMS record
- ‘Calm urgency’: How 1 Louisiana CFO tackles transportation, payer pressure and margins
- Moody’s downgrades Children’s Hospital of Los Angeles’ credit rating
- What the Health? From KFF Health News: 40 Years of Health Policy
- Salesforce partners with HealthEx, Verily and Viz.ai to build out healthcare AI agents
- J&J's Tecvayli-Darzalex multiple myeloma combo takes home FDA's 3rd national priority nod
- Rising Tree Pollen Counts Signal Start of Allergy Season
- Experts call for more data, collaboration to address gun violence at annual Northwell forum
- Finding the Right Supportive Footwear for Pain Relief is Key, Say Podiatrists
- FTC seeing 'progress' in discussions with Optum, Caremark in insulin case
- Fewer Mothers Died During Pregnancy or After Birth in 2024
- Trader Joe's Pulls Frozen Meals Tied to 37 Million-Pound Nationwide Recall
- Optum teams with Microsoft to expand AI-powered claims platform
- RadNet Acquires Gleamer to Support Position as a Radiology Clinical AI Solutions Leader
- RadNet Acquires Gleamer to Support Position as a Radiology Clinical AI Solutions Leader
- Study: PE's primary care purchases add clinicians, but also increase turnover
- Ultrasound AI Receives FDA De Novo Clearance for Delivery Date AI Technology
- Ultrasound AI Receives FDA De Novo Clearance for Delivery Date AI Technology
- Abbott CardioMEMS™ remote heart failure monitoring reader receives FDA approval
- Abbott CardioMEMS™ remote heart failure monitoring reader receives FDA approval
- As AI evolves, the modern R&D lab is changing
- Dozens of medical schools meet RFK Jr.'s call for greater nutrition education
- BD Gets CE Mark for Revello Vascular Covered Stent
- BD Gets CE Mark for Revello Vascular Covered Stent
- FDA gives Glenmark thumbs up for first 'true' generic version of GSK's asthma inhaler Flovent
- After generic defense fails, Merck KGaA assumes no US Mavenclad sales after March
- Fitness Trackers Might Help Predict Multiple Sclerosis Progression
- Dentists Can Help Detect Undiagnosed Diabetes, Study Argues
- Half of Americans Unaware of At-Home Colon Cancer Screening Options
- Ultra-Processed Foods Linked To Emotional, Behavioral Problems In Preschoolers
- Study Links Rising Cannabis Use to Poor Mental Health
- Testosterone Therapy Could Mean Trouble For Knee Replacement Patients, Study Warns
- Galderma doubles Nemluvio peak sales projection to $4B-plus after strong atopic dermatitis launch year
- Leo roars onto Netflix with DTC campaign for new hand eczema cream Anzupgo
- Con la presencia del ICE, habitantes de Minnesota crearon un sistema médico en las sombras. Un aprendizaje para otras ciudades
- Trump’s Cuts to Medicaid Threaten Services That Help Disabled People Live at Home
- Listen: What To Do When Health Insurance Slips Out of Reach
- As ICE Moved In, Minnesotans Set Up a Shadow Medical System. It’s a Lesson for Other Cities.
- Forma Life Sciences launches with oral solid dose focus, joining class of new CDMOs
- AWS offers agentic AI solution to tackle scheduling, ambient note-taking and medical coding
- Opening Remarks at Private Markets Roundtable
- Eli Lilly launches its direct-to-employer platform for obesity drugs
- Eli Lilly launches its direct-to-employer platform for obesity drugs
- Hospitals decry drugmakers' expanded claims reporting policies for 340B
- CVS unveils Health 100, its new Google-powered consumer engagement platform
- Remarks at Financial Stability Oversight Council Artificial Intelligence Innovation Series Roundtable on Strategy and Governance Principles
- Collegium enrolls Paris Hilton in Jornay PM push encouraging ADHD community to 'Embrace Your Sparkle'
- Review of U.S. Measles Elimination Status Delayed Until November
- Your Furry Roommate May Be Affecting The Air You Breathe
- BioDuro enters Taiwan joint venture, adding commercial API plant to production network
- FDA answers Vanda's yearslong call for public hearing on unsuccessful jet lag approval bid
- MUSC Health acquires South Carolina's largest multispecialty practice for $111M
- About 81,000 Baby Monitors Recalled Over Possible Fire Risk
- Armed with funding and an acquisition, Procode AI launches AI-powered RCM for surgical billing
- Charities merge to form nation's 'most comprehensive' patient assistance nonprofit
- Two Days of Oatmeal May Lower Cholesterol, Study Finds
- Bayer looking at another year of 'resilience' before growth kicks in behind Nubeqa, Kerendia
- Colorectal Cancer Rates Shifting to Younger Groups as Rectal Cancer Rates Spike
- Brain Chemical Provides A 'Pep In Your Step,' Experiment Shows
- Lithium Might Slow Brain Decline Among Seniors, Pilot Study Shows
- Exercise Boosts Quality of Life During Breast Cancer Chemotherapy
- Early Sports Specialization Linked To Increased Injury Risk
- More Kids, Teens Injured In E-Bike Wrecks, Study Finds
- Novo lands another FDA untitled letter, this time for Apple-inspired Ozempic ad
- Moderna fronts $950M to settle yearslong COVID patent litigation with Genevant, Arbutus
- Despite Their Successes, Some Mobile Crisis Response Teams Are in Crisis
- Healthcare’s mixed Q4, plus insights from the Lake Nona Impact Forum
- FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters
- HCA Healthcare says all-time high inpatient occupancy, ACA exchange attrition won't spoil 2026 volume growth
- Papa rolls out new program for insurers called Papa Plus
- AI Therapist? It Falls Short, a New Study Warns
- Grow Therapy scores $150M to build out enterprise partnerships with docs, employers
- Nearly 20 States Scale Back HIV Medication Programs
- BBQ Sauce Recall Issued Nationwide Due To Incorrect Label
- FDA Recalls More Than 651,000 Jugs of Water Over Sanitation Concerns
President Trump signed an executive order yesterday directing the federal government to promote addiction recovery:
ADDRESSING ADDICTION THROUGH THE GREAT AMERICAN RECOVERY INITIATIVE
Executive Orders
January 29, 2026By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered:
Section 1. Purpose and Policy. The disease of addiction, also known as substance use disorder, is a crisis that touches families in every community and neighborhood in our Nation. 48.4 million Americans, or 16.8 percent of our Nation’s population, suffer from addiction, and my Administration will continue to respond to a crisis of this scale with the attention it deserves. Over the past year, we have made incredible progress in stopping the inflow of illegal drugs that threaten American communities. We must now supplement that work by furthering a national effort to prioritize addiction treatment and recovery.
Addiction is a chronic, treatable disease with relapse rates similar to other chronic diseases. Unfortunately, very few Americans who need treatment ever receive it or believe they need it. Among the 40.7 million adults who had a substance use disorder in 2024 and did not receive substance use treatment, 95.6 percent (or 38.1 million people) did not perceive that they needed treatment. Despite significant investment of resources, addiction recovery efforts remain fragmented and do not keep pace with scientific advancements.
The costs of these failures are devastating, not only in lives lost, but also in the ripple effects across our economy, workforce, and national strength. Addiction contributes to declining workforce participation, increased healthcare costs, homelessness, family instability, and lost productivity that together cost the United States hundreds of billions of dollars each year.
The framework for addiction treatment should parallel that of other chronic diseases — utilizing evidence-based care, scientific advancement, continuous support, and community connection. My Administration will drive a new national response to the disease of addiction that will create stronger coordination across government, the healthcare sector, faith communities, and the private sector in order to save lives, restore families, strengthen our communities, and build the Great American Recovery.
Section 2. Launching the Great American Recovery Initiative. (a) There is hereby established the White House Great American Recovery Initiative (Initiative) co-chaired by the Secretary of Health and Human Services and the Senior Advisor for Addiction Recovery. There shall be an Executive Director who shall administer and execute the day to day operations of the Initiative, and who shall report to the Assistant to the President for Domestic Policy.
(b) In addition to the Co-Chairs and the Executive Director, the Initiative shall consist of the following officials, or their designees:
(i) the Attorney General;
(ii) the Secretary of the Interior;
(iii) the Secretary of Education;
(iv) the Secretary of Labor;
(v) the Secretary of Housing and Urban Development;
(vi) the Secretary of Veterans Affairs;
(vii) the Assistant to the President and Chief of Staff;
(viii) the Assistant to the President and Special Envoy for Peace Missions;
(ix) the Assistant to the President and Cabinet Secretary;
(x) the Director of National Drug Control Policy;
(xi) the Administrator of the Centers for Medicare and Medicaid Services;
(xii) the Commissioner of Food and Drugs;
(xiii) the Director of the National Institutes of Health;
(xiv) the Assistant Secretary for Mental Health and Substance Use, Department of Health and Human Services; and
(xv) the heads of such other executive departments, agencies, and offices that the Co-Chairs and the Executive Director may from time to time designate or invite to participate.
(c) The Co-Chairs may hold public hearings, meetings, roundtables, and similar events, as appropriate, and may receive expert input from leaders in public health, addiction and recovery treatment, and other relevant subject matter areas.
Section 3. Addressing the Disease of Addiction. The Co-Chairs and the Executive Director, along with the other members of the Initiative, shall:
(i) recommend all necessary steps to coordinate the Federal Government’s response to the addiction crisis, including by better aligning relevant Federal programs, setting clear objectives, and providing data-driven updates to the public on progress towards meeting these objectives;
(ii) take appropriate actions to increase awareness of the disease of addiction, help Americans receive the treatment they need, and foster a culture that celebrates recovery;
(iii) advise heads of executive departments and agencies (agency heads) on how to implement programs that integrate prevention, early intervention, treatment, recovery support, and re-entry into all relevant public health, healthcare, criminal justice, workforce, education, housing and social services systems, and remove outdated silos between agencies, programs, or systems, in each case as deemed appropriate by the agency head and consistent with applicable law;
(iv) advise agency heads on directing appropriate grants to support addiction recovery, with a focus on prevention, treatment, and long-term resilience; and
(v) consult with States, tribal nations, local jurisdictions, community-based organizations, faith‑based organizations, the private sector, and philanthropic entities on the best strategies to ensure more Americans receive the treatment they need and celebrate individuals going through the recovery process.
Section 4. General Provisions. (a) Nothing in this order shall be construed to impair or otherwise affect:
(i) the authority granted by law to an executive department or agency, or the head thereof; or
(ii) the functions of the Director of the Office of Management and Budget relating to budgetary, administrative, or legislative proposals.
(b) This order shall be implemented consistent with applicable law and subject to the availability of appropriations.
(c) This order is not intended to, and does not, create any right or benefit, substantive or procedural, enforceable at law or in equity by any party against the United States, its departments, agencies, or entities, its officers, employees, or agents, or any other person.
(d) The costs for publication of this order shall be borne by the Department of Health and Human Services.
DONALD J. TRUMP
THE WHITE HOUSE,
January 29, 2026.
The White House Fact Sheet:
Fact Sheet: President Donald J. Trump Launches the Great American Recovery Initiative to Address the Addiction Crisis
The White House
January 29, 2026LAUNCHING THE GREAT AMERICAN RECOVERY INITIATIVE: Today, President Donald J. Trump signed an Executive Order creating the White House Great American Recovery Initiative to coordinate a national response to the disease of addiction across government, healthcare, faith communities, and the private sector in order to save lives, restore families, strengthen our communities, and build the Great American Recovery.
The Order establishes the Initiative, co-chaired by the Secretary of Health and Human Services and the Senior Advisor for Addiction Recovery.
- Additional members of the Initiative include an executive director, cabinet secretaries, and senior administration leaders, some with deeply personal ties to the addiction crisis who are committed to ensuring Americans get the help they need.
The Order directs the Initiative to:
- Recommend all necessary steps to coordinate the Federal Government’s response to the addiction crisis, including by better aligning relevant Federal programs, setting clear objectives, and providing data-driven updates to the public on progress towards meeting these objectives;
- Take appropriate actions to increase awareness of the disease of addiction, help Americans receive the treatment they need, and foster a culture that celebrates recovery;
- Advise agencies on how to implement programs that integrate prevention, early intervention, treatment, recovery support, and re-entry;
- Advise agencies on directing appropriate grants to support addiction recovery, with a focus on prevention, treatment, and long-term resilience; and
- Consult with States, tribal nations, local jurisdictions, community-based organizations, faith-based organizations, the private sector, and philanthropic entities on the best strategies to ensure more Americans receive the treatment they need and celebrate individuals going through the recovery process.
MAKING PROGRESS ON THE DISEASE OF ADDICTION: The disease of addiction, also known as substance use disorder, is a crisis that touches families in every community in our Nation.
- Addiction is a chronic, treatable disease with relapse rates similar to other chronic diseases.
- 48.4 million Americans, or 16.8% of our Nation’s population, suffer from addiction, yet very few who need treatment receive it or believe they need it.
- Among the 40.7 million adults with a substance use disorder in 2024 who did not receive treatment, 95.6% (or 38.1 million people) did not perceive they needed it.
- Addiction contributes to declining workforce participation, increased healthcare costs, homelessness, family instability, and lost productivity that together cost the United States hundreds of billions of dollars each year.
- The framework for addiction treatment should parallel that of other chronic diseases – utilizing evidence-based care, scientific advancement, continuous support, and community connection.
DELIVERING ON PROMISES TO ADDRESS THE ADDICTION CRISIS: President Trump is committed to ending the addiction crisis and ensuring every American can access the help they need.
- He signed the SUPPORT Patients and Communities Reauthorization Act of 2025, strengthening Federal programs that address substance use disorders, overdoses, and mental health.
- He has taken aggressive action to stop the flow of deadly drugs into the United States, determined to save lives from the devastation caused by illicit narcotics crossing the border.
- He signed into law the HALT Fentanyl Act to permanently place Fentanyl-related substances into Schedule I of the Controlled Substances Act.
- His Administration is working to prevent drug use before it starts, strengthen treatment that leads to long-term recovery, and advance research and data to support effective drug control strategies.
- These efforts build on historic actions from President Trump’s first term, when he:
- Declared the opioid crisis a nationwide public health emergency.
- Signed the SUPPORT for Patients and Communities Act, the largest-ever legislative effort to address a drug crisis in our Nation’s history.
- Launched the Initiative to Stop Opioid Abuse and Reduce Drug Supply and Demand in order to confront the many causes fueling the drug crisis.
- Signed the CRIB Act, allowing Medicaid to help mothers and their babies who are born physically dependent on opioids by covering their care in residential pediatric recovery facilities.
- Distributed $1 billion in grants for addiction prevention and treatment.
- Announced a Safer Prescriber Plan to decrease the number of opioid prescriptions filled.
- Expanded access to medication-assisted treatment and life-saving Naloxone.
- Launched FindTreatment.gov, a tool to find help for substance abuse.
- Approved 29 state Medicaid demonstrations to improve access to opioid use disorder treatment, including new flexibility to cover inpatient and residential treatment.
The $ 100 million HHS pilot program:
Secretary Kennedy Announces $100 Million Investment in Great American Recovery
FOR IMMEDIATE RELEASE February 2, 2026
HHS Press Office
202-690-6343OXON HILL, MARYLAND — FEBRUARY 2, 2026 — Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. today announced a comprehensive plan to strengthen prevention, expand treatment, and carry out the executive order President Trump signed last week to ignite the Great American Recovery. The centerpiece of this plan is a $100 million investment to solve long-standing homelessness issues, fight opioid addiction, and improve public safety by expanding treatment that emphasizes recovery and self-sufficiency.
The Safety Through Recovery, Engagement, and Evidence-based Treatment and Supports — or STREETS — Initiative will fund targeted outreach, psychiatric care, medical stabilization and crisis intervention, while connecting Americans experiencing homelessness and addiction to stable housing with a clear focus on long-term recovery and independence.
“Addiction begins in isolation and ends in reconnection,” said Secretary Kennedy, who is co-chair of President Trump’s Great American Recovery Initiative. “Thanks to the leadership of President Trump, we are bringing Americans suffering from addiction out of the shadows and back into community.
”Secretary Kennedy made the announcement at Prevention Day, the largest government-sponsored gathering dedicated to advancing the prevention of substance use, hosted by the Substance Abuse and Mental Health Services Administration (SAMHSA), a division of HHS.
The $100 million investment directed by Secretary Kennedy is a clear departure from Biden-era policies that were misguided, failing to stem the tide of death, addiction, homelessness, and crime in American communities. These policies focused not on preventing and treating individuals, but rather non-effective interventions such as harm reduction, supporting housing first, and other strategies that enabled future drug use — and were never intended to support people in their recovery to lead productive lives in their communities.
Substance use disorder — impairment caused by repeated use of alcohol or other drugs — among people ages 12 and older rose from 7.4% in 2019 to 16.8% in 2024, according to SAMHSA survey data. Nearly 8 in 10 people with a substance use disorder in 2024 did not receive treatment.
Secretary Kennedy also announced the $10 million Assisted Outpatient Treatment (AOT) grant program to support adults with serious mental illness. AOT is a civil court-ordered, community-based outpatient mental health treatment program for adults with serious mental illness who are unable to engage with conventional outpatient treatment and are unlikely to be able to live safely in their community. The program is designed to work within the civil court system that supports engagement with community-based treatment as an alternative to more costly restrictive levels of care, homelessness, and interactions with the criminal justice system.
President Trump’s Executive Order Ending Crime and Disorder on America’s Streets on July 24, 2025 directed SAMHSA grants toward evidence-based substance use disorder programs with proven results and assisted outpatient treatment that moves people with serious mental illness or addiction off the streets and into stable housing and support networks. SAMHSA in September 2025 awarded more than $45 million in new supplemental funding to State Opioid Response program recipients to focus on sober or recovery housing among young adults.
The STREETS Initiative and AOT grant announcements coincide with SAMHSA’s $794 million first allocation of 2026 annual block grant awards, with $319 million going to support comprehensive community mental health services for adults with serious mental illness and children with serious emotional disturbance, and $475 million to the agency’s Substance Use Prevention, Treatment, and Recovery Services Block Grant program to prevent and treat substance abuse.
To help prevent family breakdown from substance use disorder, HHS’ Administration for Children and Families today under Secretary Kennedy’s plan added three Medications for Opioid Use Disorder (MOUD) as prevention services eligible for federal funding. States and tribes can now receive a 50% federal match, respectively, to provide buprenorphine, methadone, and naltrexone to parents when children are at imminent risk of entering foster care but can remain safely in the home or in a kinship placement with access to these treatments.
All three MOUD are U.S. Food and Drug Administration-approved, well-established, evidence-based tools that support recovery, promote family stability, and reduce risk factors associated with child welfare involvement.
SAMHSA and ACF intend to issue a Dear Colleague letter to emphasize that both agencies welcome full participation from faith-based organizations in their programs and activities.
President Trump declared upon establishing the White House Faith Office on February 7, 2025, “The executive branch wants faith-based entities, community organizations, and houses of worship, to the fullest extent permitted by law, to compete on a level playing field for grants, contracts, programs, and other Federal funding opportunities.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















